Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-20-000887
Filing Date
2020-03-24
Accepted
2020-03-24 16:05:56
Documents
7
Effectiveness Date
2020-03-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS gild3646261-defa14a.htm DEFA14A 38376
2 GRAPHIC d364626x1x1.jpg GRAPHIC 12769
3 GRAPHIC d364626x87x1.jpg GRAPHIC 1858
4 GRAPHIC d364626x87x2.jpg GRAPHIC 5635
5 GRAPHIC d364626x88x1.jpg GRAPHIC 1987
6 GRAPHIC d364626x89x1.jpg GRAPHIC 1843
7 GRAPHIC d364626x90x1.jpg GRAPHIC 1667
  Complete submission text file 0001206774-20-000887.txt   75711
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19731 | Film No.: 20738424
SIC: 2836 Biological Products, (No Diagnostic Substances)